Daily use of high-potency cannabis is associated with an increased risk of admission and more intervention after first-episode psychosis

Evidence-Based Mental Health

Volumn 20, Issue 2, 2017, Pages 58-

  Large, Matthew ^a   Nielssen, Olav ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABIS;

HUMAN; PSYCHOSIS; RISK;

CANNABINOIDS; CANNABIS; HUMANS; PSYCHOTIC DISORDERS; RISK;

EID: 85018414489     PISSN: 13620347     EISSN: None     Source Type: Journal    
DOI: 10.1136/eb-2017-102630     Document Type: Note

References (6)

1. Matheson SL, Shepherd AM, Carr VJ. How much do we know about schizophrenia and how well do we know it? Psychol Med 2014;44:3387-405.
2. Moore TH, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007;370:319-28.
3. Myles N, Newall H, Nielssen O, et al. The association between cannabis use and earlier age at onset of schizophrenia and other psychoses: meta-analysis of possible confounding factors. Curr Pharm Des 2012;18:5055-69.
4. Myles H, Myles N, Large M. Cannabis in first episode psychosis: prevalence, time course of initiation and continued use. Aust N Z J Psychiatry 2016;50:208-19.
5. Mullin K, Gupta P, Compton MT, et al. Does giving up substance use work for patients with psychosis? Aust N Z J Psychiatry 2012;46:826-39.
6. Schoeler T, Monk A, Sami MB, et al. Continued versus discontinued cannabis use in patients with psychosis: a systematic review. Lancet Psychiatry 2016;3:215-25.